Traditional Chinese medicine composition for curing hepatitis B

Abstract

The invention provides a traditional Chinese medicine composition for curing hepatitis B. The traditional Chinese medicine composition includes, by weight, 12 parts of polygonum cuspidatum, 12 parts of artemisia scoparia waldst, 10 parts of radix scutellariae, 10 parts of oldenlandia, 10 parts of radix paeoniae alba, 8 parts of epimedium herb, 10 parts of rehmannia glutinosa, 12 parts of flos chrysanthemi indici, 8 parts of red tangerine peel and 3 parts of licorice. The traditional Chinese medicine composition has effects of clearing heat and removing toxicity, norishing blood and liver, nourishing Yin and tonifying Yang, and regulating vital energy and removing stasis; and has remarkable efficacy on the hepatitis B.

Description

technical field [0001] The invention relates to a medicine for treating hepatitis B, in particular to a composition for treating hepatitis B prepared from Chinese herbal medicine. Background technique [0002] Chinese medicine believes that the main pathological factors of hepatitis B are dampness, heat and blood stasis, and the liver disease is easy to spread to the spleen and kidney for a long time, resulting in the same disease of the liver, spleen and kidney, and even develops into cirrhosis of the liver, with liver ascites. Seriously affect the quality of life of patients and may even cause life-threatening. [0003] Compared with the treatment of hepatitis B by western medicine, traditional Chinese medicine treatment has the advantages of low cost and few adverse reactions, but the existing clinical treatment drugs also have problems such as long treatment time, inaccurate curative effect, and low cure rate. Contents of the invention [0004] In order to solve t...

AI Technical Summary

Problems solved by technology

Seriously affect the quality of life of patients and may even cause life-threatening

[0003] Compared with the treatment of hepatitis B by western medicine, the treatment of traditional Chinese medicine has the advantages of low cost and less adverse reactions, but the existing clinical treatment drugs also have problems such as long treatment time, inaccurate curative effect, and low cure rate.